The results indicated that the mRNA expression of KMO was significantly higher in invasive ductal breast carcinoma, invasive lobular breast carcinoma, lobular breast carcinoma, invasive breast carcinoma, and ductal breast carcinoma in situ compared with matched normal tissues. This evidence concerns the gene KMO and breast lobular carcinoma.